Results

Total Results: 860 records

Showing results for "adverse drug events".
Users also searched for: pressure injury

141. Medical Injury Identification Using Hospital Discharge Data (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-safety-resources/resources/advances-in-patient-safety/vol2/Layde.pdf
     January 01, 2003 - National systems are voluntary and most focus on relatively few types of reportable events, such as adverse … drug events or nosocomial infections.

142. Medications at Transitions and Clinical Handoffs (MATCH) Toolkit for Medication Reconciliation | Agency for Healthcare Research and Quality
     www.ahrq.gov/patient-safety/settings/hospital/match/index.html
     April 01, 2023 - process can detect and avert most medication discrepancies, potentially avoiding a large number of adverse … drug events and related costs for care of affected patients.

143. Medications at Transitions and Clinical Handoffs (MATCH) Toolkit for Medication Reconciliation | Agency for Healthcare Research and Quality
     www.ahrq.gov/es/patient-safety/settings/hospital/match/index.html
     April 01, 2023 - process can detect and avert most medication discrepancies, potentially avoiding a large number of adverse … drug events and related costs for care of affected patients.

144. Preventing Medication Errors Among Children With Chronic Conditions in Outpatient and Home Settings | Agency for Healthcare Research and Quality
     www.ahrq.gov/funding/grantee-profiles/grtprofile-walsh.html
     October 01, 2023 - Walsh is working to prevent medication errors and adverse drug events among children, particularly those … Her team found that 10 percent of children with leukemia or lymphoma experienced adverse drug events

145. Private Sector Efforts in Value-Based Purchasing and Quality Improvement | Agency for Healthcare Research and Quality
     www.ahrq.gov/patient-safety/quality-measures/21st-century/private-sector.html
     June 01, 2018 - Incidence of adverse drug events and potential adverse drug events: implications for prevention. … The costs of adverse drug events in hospitalized patients. … Adverse Drug Events in Hospitalized Patients: Excess Length of Stay, Extra Costs, and Attributable Mortality … Breakthrough Series Guide: Reducing Adverse Drug Events .

146. Return on Investment Tool (doc file)
     www.ahrq.gov/sites/default/files/wysiwyg/professionals/systems/hospital/qitoolkit/pdi/f1_pdi_returnoninvestment.docx
     January 01, 2013 - For many components of the CPOE, the number of estimated adverse drug events (ADEs) averted was multiplied … printers, software, network, leadership, and training Returns (numerator) $28.5 million Averted adverse … drug events; medication cost savings; decreased laboratory test usage for redundant or unnecessary tests … The cost of adverse drug events in hospitalized patients. JAMA 1997;277:307-11. … Adverse drug events in hospitalized patients: excess length of stay, extra costs, and attributable mortality

147. Final Progress Report: Interactive HIT to promote ambulatory safety among vulnerable diabetes patients (pdf file)
     www.ahrq.gov/sites/default/files/2024-11/sarkar-report.pdf
     January 01, 2024 - Adverse drug events in U.S. adult ambulatory medical care. Health Serv Res. … Signal and noise: applying a laboratory trigger tool to identify adverse drug events among primary care

148. Return on Investment Tool (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/professionals/systems/hospital/qitoolkit/combined/f1_combo_returnoninvestment.pdf
     January 01, 2013 - For many components of the CPOE, the number of estimated adverse drug events (ADEs) averted was multiplied … printers, software, network, leadership, and training Returns (numerator) $28.5 million Averted adverse … drug events; medication cost savings; decreased laboratory test usage for redundant or unnecessary … The cost of adverse drug events in hospitalized patients. JAMA 1997;277:307-11. … Adverse drug events in hospitalized patients: excess length of stay, extra costs, and attributable mortality

149. Acknowledgments | Agency for Healthcare Research and Quality
     www.ahrq.gov/patient-safety/reports/liability/acknowledgements.html
     August 01, 2017 - Transitional Care Medication Safety: Stakeholders' Perspectives Medication Discrepancies and Potential Adverse … Drug Events During Transfer of Care from Hospital to Home Advances in Patient Safety

150. Patients Safer as Hospital-Acquired Conditions Decline (Data Graphic) (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/data/infographics/hac-interim-data-graphic-2014.pdf
     January 01, 2014 - 2.1 MILLION 2.1 MILLION From 2010–2014, 17 percent of hospital-acquired conditions (HACs) such as adverse … drug events, healthcare-associated infections, and pressure ulcers have been prevented in hospital

151. Oregon Rural Practice-based Research Network | Agency for Healthcare Research and Quality
     www.ahrq.gov/ncepcr/communities/pbrn/registry/oregon-rural-practice-based-research-network.html
     May 06, 2013 - diesease related interests: Access to care-dental services, drug sampling policies, medication errors and adverse … drug events, patient-centered primary care home, practice transformation, rural health delivery systems

152. Updated Information on the Annual Hospital-Acquired Condition Rate: 2011 and 2012 (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/pfp/updatedhacrateinfo.pdf
     June 01, 2014 - 32,750,000 Discharges— Based on 2010 Baseline) 2012 PFP Measured HACs per 1,000 Discharge s Adverse … Drug Event (ADE) MPSMS ADE Associated With Digoxin 9,400 0.29 11,000 0.32 MPSMS ADE Associated

153. INSTRUCTIONS: Return on Investment Estimation (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/professionals/systems/hospital/qitoolkit/f1-returnoninvestment.pdf
     January 01, 2009 - For many components of the CPOE, the number of estimated adverse drug events (ADE) averted was multiplied … printers, software, network, leadership, and training Returns (numerator) $28.5 million Averted adverse … drug events; medication cost savings; decreased laboratory test usage for redundant or unnecessary … The cost of adverse drug events in hospitalized patients. JAMA 1997;277:307-11. … Adverse drug events in hospitalized patients: excess length of stay, extra costs and attributable mortality

154. Resources and Tools To Improve Discharge and Transitions of Care and Reduce Readmissions | Agency for Healthcare Research and Quality
     www.ahrq.gov/patient-safety/about/areas/improve-discharge.html
     August 01, 2024 - Patient Safety and Team Communication Through Daily Huddles AHRQ PSNet Primer: Medication Errors and Adverse … Drug Events AHRQ PSNet Primer: Medication Reconciliation AHRQ PSNet Perspective: Patient Safety in the

155. Interim Update on 2013 Annual Hospital-Acquired Condition Rate and Estimates of Cost Savings and Deaths Averted From 2010 to 2013 | Agency for Healthcare Research and Quality
     www.ahrq.gov/hai/pfp/interimhac2013-ap2.html
     December 01, 2014 - vs. 2010, and Baseline Projections Made in 2011 on the Additional Inpatient Mortality per HAC Adverse … Drug Events 1,621,000 1,320,000 301,000 19% $1,505,000,000 6,020 Catheter-Associated

156. Executive Summary | Agency for Healthcare Research and Quality
     www.ahrq.gov/patient-safety/reports/candor-demo-program/plan-grants/summary.html
     August 01, 2022 - occurred across all types of medications and in 41% of cases sampled in this study may have caused adverse … drug events.

157. Return on Investment Estimation (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/professionals/systems/hospital/qitoolkit/pdi/f1_pdi_returnoninvestment.pdf
     January 01, 2013 - For many components of the CPOE, the number of estimated adverse drug events (ADEs) averted was multiplied … printers, software, network, leadership, and training Returns (numerator) $28.5 million Averted adverse … drug events; medication cost savings; decreased laboratory test usage for redundant or unnecessary … The cost of adverse drug events in hospitalized patients. JAMA 1997;277:307-11. … Adverse drug events in hospitalized patients: excess length of stay, extra costs, and attributable mortality

158. Ohio Veterans’ Facility Relied on AHRQ Resource to Develop Diabetes Initiative | Agency for Healthcare Research and Quality
     www.ahrq.gov/news/newsroom/case-studies/202301.html
     October 01, 2024 - AHRQ Product(s): SHARE Approach Topic(s): Access to Care, Adverse … Drug Events (ADE), Care Coordination, Chronic Conditions, Clinician-Patient Communication

159. Final Progress Report: Show Your Work: Do Prescription Annotations Impact Near-miss Medication Errors? (pdf file)
     www.ahrq.gov/sites/default/files/2024-01/johnson-baughman-report.pdf
     January 01, 2024 - an incidence ranging from 7.8% to 21% in the published literature.5-10 The details about errors and adverse … drug events associated with the prescribing process have been well described in recent Institute of … drug events each year, which would prevent nearly 1.3 million provider visits and about 14 preventable … adverse drug events per provider each year.15 The use of e-prescribing systems adds an additional level … Impact of Basic Computerized Prescribing on Outpatient Medication Errors and Adverse Drug Events.

160. Development of a Multipurpose Dataset to Evaluate Potential Medication Errors in Ambulatory Settings (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-safety-resources/resources/advances-in-patient-safety/vol2/Chan.pdf
     July 01, 2004 - system of the Food and Drug Administration (FDA) includes reports of medical errors among the 300,000 adverse … drug event reports it receives each year,4 investigators cannot use these reports to evaluate the frequency … care organizations before and after release of results of Women’s Health Initiative Detection of adverse … drug reactions (funded by AHRQ) Utilize the Patient Safety dataset to evaluate the performance of … Incidence of adverse drug events and potential adverse drug events. Implications for prevention.